STOCK TITAN

Sapiens International Corporation N.V. (SPNS) Financials

SPNS
FY2024 annual
Revenue $542.4M +5.4% YoY
Net Income $72.2M +15.6% YoY
EPS (Diluted) $1.29 +15.2% YoY
Free Cash Flow $79.3M +3.2% YoY
Source SEC Filings (10-K/10-Q) Latest period FY2024, ended Dec 31, 2024 Reported Currency USD FYE December

Newest figures come from the 10-K for FY2024, filed Mar 27, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SPNS SEC filings page.

Sapiens International Corporation N.V. (SPNS) reported $542.4M in revenue for fiscal year 2024, up 5.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SPNS FY2024

Sapiens is becoming more cash-generative and less debt-dependent, with widening margins and modest reinvestment needs.

The earnings pattern is unusually cash-consistent: operating cash flow exceeded net income in both FY2023 and FY2024, while FY2024 free cash flow reached 14.6% of revenue. That combination indicates reported profits are converting into cash without heavy capital spending, strengthening the quality of earnings.

Margin expansion is doing more work than topline growth: gross margin rose from 42.7% in FY2023 to 43.9% in FY2024. Operating margin also increased from 15.3% to 15.8% despite higher operating expenses, consistent with better gross economics and partial operating leverage rather than simple expense cutting.

The financing posture has materially strengthened: total liabilities fell from $242M in FY2023 to $212M in FY2024. Equity increased over the same period, and a 2.2x current ratio indicates more short-term balance-sheet cushion alongside reduced creditor dependence.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 76 / 100
Financial Health Score 76/100

Scored against operating companies for FY2024. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Sapiens International Corporation N.V.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
83

Sapiens International Corporation N.V. has an operating margin of 15.8%, meaning the company retains $16 of operating profit per $100 of revenue. This strong profitability earns a score of 83/100, reflecting efficient cost management and pricing power. This is up from 15.3% the prior year.

Growth
56

Sapiens International Corporation N.V.'s revenue grew 5.4% year-over-year to $542.4M, a solid pace of expansion. This earns a growth score of 56/100.

Leverage
97

Sapiens International Corporation N.V. carries a low D/E ratio of 0.04, meaning only $0.04 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
65

With a current ratio of 2.24, Sapiens International Corporation N.V. holds $2.24 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 65/100.

Cash Flow
75

Sapiens International Corporation N.V. converts 14.6% of revenue into free cash flow ($79.3M). This strong cash generation earns a score of 75/100.

Returns
82

Sapiens International Corporation N.V. earns a strong 15.0% return on equity (ROE), meaning it generates $15 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 82/100. This is up from 14.0% the prior year.

Altman Z-Score Safe
8.71

Sapiens International Corporation N.V. scores 8.71, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.4B) relative to total liabilities ($212.1M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong
8/9

Sapiens International Corporation N.V. passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.14x

For every $1 of reported earnings, Sapiens International Corporation N.V. generates $1.14 in operating cash flow ($82.2M OCF vs $72.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
15.71x

Sapiens International Corporation N.V. earns $15.71 in operating income for every $1 of interest expense ($85.8M vs $5.5M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2024.

Cash & Balance Sheet

Cash & Debt
$163.7M
YoY+29.2%
QoQ+29.2%

Sapiens International Corporation N.V. held $163.7M in cash against $19.8M in long-term debt as of Q4 2024.

Shares Outstanding
56M
YoY+0.3%
QoQ+0.3%

Sapiens International Corporation N.V. had 56M shares outstanding in Q4 2024. This represents an increase of 0.3% from the same quarter a year earlier. Against the prior quarter it is up 0.3%.

Free Cash Flow

Not reported for Q4 2024.

Dividends Per Share

Not reported for Q4 2024.

Margins & Returns

None of these metrics is reported for Q4 2024.

Capital Allocation

None of these metrics is reported for Q4 2024.

SPNS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPNS quarterly income statement
MetricQ4'2410-KQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-KQ2'2010-QQ4'1910-KQ4'1810-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

SPNS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPNS quarterly balance sheet
MetricQ4'2410-KQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-KQ2'2010-QQ4'1910-KQ4'1810-K
Total Assets$691.7M+0.3%$689.6M+3.2%$668.3M-6.5%$715.0M+0.1%$714.2M+57.9%$527.3M$452.4M+19.4%$378.9M+1.4%
Current Assets$335.1M+6.4%$314.9M+10.4%$285.3M-5.0%$300.3M+12.3%$267.4M+81.6%$200.0M$147.2M+13.2%$130.0M-0.7%
Cash & Equivalents$163.7M+29.2%$126.7M-20.9%$160.3M-15.7%$190.2M+24.7%$152.6M+130.1%$128.0M$66.3M+2.6%$64.6M-9.6%
Short-Term Investments$52.5M-30.4%$75.4M+277.0%$20.0M0.0%$20.0M-33.3%$30.0M+31.1%$0$22.9M$0
Accounts Receivable$58.8M-2.1%$60.0M+2.5%$58.6M+8.5%$54.0M+11.0%$48.6M+40.5%$45.9M$34.6M-11.1%$39.0M-6.6%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$251.5M-1.9%$256.3M+1.6%$252.2M-3.4%$261.1M-1.2%$264.3M+54.8%$186.1M$170.7M+2.8%$166.1M+4.8%
Total Liabilities$212.1M-12.5%$242.4M-9.5%$267.8M-13.2%$308.4M-7.2%$332.5M+45.4%$292.0M$228.6M+28.6%$177.8M+2.4%
Current Liabilities$149.6M+0.3%$149.1M+2.2%$146.0M-3.8%$151.7M+4.8%$144.8M+38.0%$124.1M$104.9M+29.4%$81.1M+15.6%
Non-Current Liabilities$62.5M-31.0%$90.6M-24.2%$119.5M-22.7%$154.6M-16.8%$185.7M+52.2%$165.7M$122.0M+28.1%$95.3M-5.9%
Long-Term Debt$19.8M-49.9%$39.5M-33.3%$59.3M-25.0%$79.0M-20.0%$98.7M+67.7%$98.4M$58.9M-14.2%$68.6M-12.4%
Total Equity$479.6M+7.2%$447.3M+11.7%$400.5M-1.5%$406.5M+6.5%$381.7M+70.5%$235.3M$223.8M+11.3%$201.0M+0.5%
Retained Earnings$160.2M+33.7%$119.9M+40.1%$85.6M+19.6%$71.6M+60.3%$44.6M+149.2%$27.0M$17.9M+569.9%$2.7M+120.7%

Not reported in any period shown, so not listed: Inventory.

SPNS Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPNS quarterly cash flow statement
MetricQ4'2410-KQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-KQ2'2010-QQ4'1910-KQ4'1810-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

SPNS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SPNS quarterly financial ratios
MetricQ4'2410-KQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-KQ2'2010-QQ4'1910-KQ4'1810-K
Current Ratio2.24+0.1x2.11+0.2x1.950.0x1.98+0.1x1.85+0.4x1.611.40-0.2x1.60-0.3x
Debt-to-Equity0.040.0x0.09-0.1x0.150.0x0.19-0.1x0.260.0x0.420.26-0.1x0.34-0.1x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Sapiens International Corporation N.V. SPNS FY2024 $542.4M $72.2M 13.3% $2.4B 76/100
Alkami Technology, Inc. ALKT FY2025 $443.6M -$47.7M -10.7% $1.6B 50/100
Diebold Nixdorf, Incorporated DBD FY2025 $3.8B $94.6M 2.5% $2.3B 32/100
NCR Atleos Corporation NATL FY2025 $4.4B $162.0M 3.7% $3.4B 44/100
Alarm.com Holdings, Inc. ALRM FY2025 $1.0B $131.6M 13.0% $2.9B 61/100
DoubleVerify Holdings, Inc. DV FY2025 $748.3M $50.6M 6.8% $2.1B 77/100

Frequently Asked Questions

What is Sapiens International Corporation N.V.'s annual revenue?

Sapiens International Corporation N.V. (SPNS) reported $542.4M in total revenue for fiscal year 2024. This represents a 5.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Sapiens International Corporation N.V.'s revenue growing?

Sapiens International Corporation N.V. (SPNS) revenue grew by 5.4% year-over-year, from $514.6M to $542.4M in fiscal year 2024.

Is Sapiens International Corporation N.V. profitable?

Yes, Sapiens International Corporation N.V. (SPNS) reported a net income of $72.2M in fiscal year 2024, with a net profit margin of 13.3%.

Sapiens International Corporation N.V. (SPNS) reported diluted earnings per share of $1.29 for fiscal year 2024. This represents a 15.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Sapiens International Corporation N.V. (SPNS) had EBITDA of $90.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2024, Sapiens International Corporation N.V. (SPNS) had $163.7M in cash and equivalents against $19.8M in long-term debt.

Sapiens International Corporation N.V. (SPNS) had a gross margin of 43.9% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

Sapiens International Corporation N.V. (SPNS) had an operating margin of 15.8% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

Sapiens International Corporation N.V. (SPNS) had a net profit margin of 13.3% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Sapiens International Corporation N.V. (SPNS) has a return on equity of 15.0% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

Sapiens International Corporation N.V. (SPNS) generated $79.3M in free cash flow during fiscal year 2024. This represents a 3.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Sapiens International Corporation N.V. (SPNS) generated $82.2M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

Sapiens International Corporation N.V. (SPNS) had $691.7M in total assets as of fiscal year 2024, including both current and long-term assets.

Sapiens International Corporation N.V. (SPNS) invested $2.9M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Sapiens International Corporation N.V. (SPNS) invested $66.3M in research and development during fiscal year 2024.

Sapiens International Corporation N.V. (SPNS) had 56M shares outstanding as of fiscal year 2024.

Sapiens International Corporation N.V. (SPNS) had a current ratio of 2.24 as of fiscal year 2024, which is generally considered healthy.

Sapiens International Corporation N.V. (SPNS) had a debt-to-equity ratio of 0.04 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

Sapiens International Corporation N.V. (SPNS) had a return on assets of 10.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Sapiens International Corporation N.V. (SPNS) has an Altman Z-Score of 8.71, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Sapiens International Corporation N.V. (SPNS) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Sapiens International Corporation N.V. (SPNS) has an earnings quality ratio of 1.14x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Sapiens International Corporation N.V. (SPNS) has an interest coverage ratio of 15.71x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Sapiens International Corporation N.V. (SPNS) scores 76 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top